Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

lipoprotein-associated coagulation inhibitor MeSH Supplementary Concept Data 2025


MeSH Supplementary
lipoprotein-associated coagulation inhibitor
Unique ID
C051928
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C051928
Entry Term(s)
EPI I (extrinsic pathway inhibitor I)
LACI inhibitor
TFI HepG2
TFPI
TFPI-beta
TFPIbeta
Xa-dependent factor VIIa-TF inhibitor
anticonvertin
antithromboplastin
extrinsic pathway inhibitor I
tissue factor inhibitor, hepatoma
tissue factor pathway inhibitor
Pharm Action
Anticoagulants
Fibrinolytic Agents
Serine Proteinase Inhibitors
Factor Xa Inhibitors
Registry Numbers
0
E1U4X64NFM
Related Numbers
E1U4X64NFM
Previous Indexing
*FACTOR VII/*antag (87-92)
*NEOPLASM PROTEINS (87-89)
*THROMBOPLASTIN/*antag (87-92)
Heading Mapped to
*Lipoproteins
Frequency
1579
Note
MW 38,000; produced by HepG2 hepatoma & other cells; requires factor VII(a), factor X(a) & Ca++ to express inhibitory activity
Source
Proc Natl Acad Sci USA 1987;84(7):1886
Date of Entry
1987/04/30
Revision Date
2018/11/16
lipoprotein-associated coagulation inhibitor Preferred
TFI HepG2 Narrower
TFPI-beta Narrower
Xa-dependent factor VIIa-TF inhibitor Narrower
anticonvertin Narrower
LACI inhibitor Narrower
extrinsic pathway inhibitor I Narrower
tissue factor inhibitor, hepatoma Narrower
tissue factor pathway inhibitor Narrower
antithromboplastin Narrower
page delivered in 0.007s